Cytek Biosciences Inc.

NASDAQ: CTKB · Real-Time Price · USD
4.03
-0.05 (-1.23%)
At close: Aug 15, 2025, 3:59 PM
4.00
-0.62%
After-hours: Aug 15, 2025, 05:59 PM EDT

Cytek Biosciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-6.4M -11.25M -6.02M -10.16M -17.56M -11.51M -12.15M -13.93M -5.85M -2.17M 2.48M -2.4M -2.6M 767K 3.03M 9.79M 14.91M 20.35M
Depreciation & Amortization
11.42M 10.91M 10.49M 10.17M 9.92M 9.89M 9.23M 8.67M 6.88M 5.99M 5.66M 4.48M 3.9M 2.54M 1.24M 715K 705K 665K
Stock-Based Compensation
27.48M 27.84M 26.85M 25.51M 24.22M 22.99M 22.05M 20.84M 19.45M 17.46M 16.59M 15.14M 13.23M 9.97M 6.59M 3.85M 1.52M 962K
Other Working Capital
-10.24M -11.96M -17.41M -27.62M -16.38M -13.98M -5.68M 5.21M -1.64M -308K -1.85M 1.6M 9.2M 8.2M 11.04M 7.62M 7.51M -809K
Other Non-Cash Items
-2.48M 739K 2.79M 20.15M 3.96M 3.06M 1.42M -3.17M 1.38M 1.65M 2.75M 2.62M 2.32M 2.17M 1.97M 2.08M 2.05M 1.71M
Deferred Income Tax
-2.39M -336K n/a -5.72M -2.74M -4.76M -4.76M 958K -2.02M n/a n/a 155K 225K 167K 448K 293K 223K 281K
Change in Working Capital
-12.43M -4.32M -5.5M -3.84M 846K -12.36M -10.51M -11.41M -21.14M -31.03M -39.93M -33.18M -21.59M -14.4M -8.65M -5.91M -7.55M -8.32M
Operating Cash Flow
15.2M 21.3M 25.38M 32.89M 15.43M 6.38M 5.28M 1.96M -1.3M -7.89M -12.23M -12.98M -4.31M 1.22M 4.63M 10.82M 11.85M 15.65M
Capital Expenditures
-4.14M -3.76M -3.53M -4.19M -4.78M -4.94M -4.83M -9.88M -9.63M -9.59M -9.87M -4.55M -4.71M -4.63M -4.36M -3.27M -2.44M -1.71M
Cash Acquisitions
-547K -471K -471K -236K -161K -10.24M -55.37M -55.13M -55.13M -45.13M n/a -17M -16.63M -16.63M -16.26M 742K 371K 371K
Purchase of Investments
-301.5M -257.09M -274.06M -189.95M -160.6M -129.59M -175.7M -197.02M -173.53M -169.28M -46.04M -1.59M -1.59M n/a n/a n/a n/a n/a
Sales Maturities Of Investments
219.91M 193.43M 195M 204M 234M 204M 132.24M 78.23M 10.23M 235K n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
66K 3.19M 3.1M 33.49M 78.28M 85.2M 85.02M 54.38M 9.64M -1.94M -1.71M -22.62M -22.58M -20.99M -20.99M n/a n/a n/a
Investing Cash Flow
-86.2M -67.77M -82.97M 9.53M 68.46M 69.23M -93.89M -174.02M -218.3M -224M -55.91M -23.14M -23.3M -21.64M -20.99M -2.9M -2.07M -1.34M
Debt Repayment
1.68M 1.54M 3.62M 838K 835K 836K -565K 2.51M 2.65M 2.79M 2.93M n/a n/a n/a n/a n/a -1.31M -1.31M
Common Stock Repurchased
-29.57M -32.24M -21.76M -49.51M -45.99M -44.3M -44.21M -9.47M -1.11M -195K -138K -138K -67K n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-13.54M -11.01M 934K 2.48M 2.77M 3.26M 3.05M 1.71M 1.57M 2.36M 2.58M 1.68M 218.6M 213.74M 213.56M 333.27M 116.29M 124.09M
Financial Cash Flow
-29.87M -28.98M -15.82M -45.94M -42.13M -40.2M -41.61M -4M 4.42M 5.35M 5.51M 1.68M 218.6M 213.74M 213.56M 333.27M 114.98M 122.78M
Net Cash Flow
-102.45M -73.84M -68.89M -1.33M 46.37M 36.75M -131.87M -177.89M -218.35M -230.11M -65.12M -35.25M 190.05M 193.92M 198.5M 341.24M 124.52M 136.47M
Free Cash Flow
11.06M 17.54M 21.84M 28.7M 10.66M 1.44M 454K -7.91M -10.94M -17.49M -22.1M -17.53M -9.02M -3.42M 266K 7.55M 9.42M 13.94M